Acorda Therapeutics, Inc. Accrued Liabilities, Current
Acorda Therapeutics, Inc. had Accrued Liabilities, Current of $17.66 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2024-05-14
- 2024-03-31: Accrued Liabilities, Current $17.66M.
- 2023-12-31: Accrued Liabilities, Current $24.31M.
- 2023-09-30: Accrued Liabilities, Current $29.34M.
- 2023-06-30: Accrued Liabilities, Current $21.82M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2024-03-31 | $17.66M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $24.31M 10-Q · filed 2024-05-14 | |
| 2023-09-30 | $29.34M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $21.82M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $27.02M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $23.68M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $26.70M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $29.69M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $26.23M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $28.61M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $34.16M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $28.81M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $38.12M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $38.17M 10-K · filed 2022-03-18 | |
| 2020-09-30 | $41.43M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $37.48M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $36.97M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $39.08M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $43.23M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $44.59M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $45.92M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $76.88M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $97.82M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $97.76M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $91.78M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $99.85M 10-K · filed 2019-02-27 | $100.13M 10-K · filed 2018-03-01 |
| 2017-09-30 | $78.30M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $77.50M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $88.15M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $104.89M 10-K/A · filed 2018-03-09 | |
| 2016-09-30 | $89.37M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $96.39M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $73.47M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $66.13M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $68.47M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $55.53M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $60.21M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $56.12M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $39.78M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $34.06M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $31.33M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $37.57M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $29.92M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $34.21M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $31.79M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $35.76M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $23.24M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $28.20M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $20.49M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $24.15M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $19.24M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $25.00M 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $25.77M 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $33.77M 10-K · filed 2012-02-28 | $34.12M 10-K · filed 2011-03-01 |
| 2010-09-30 | $25.80M 10-Q · filed 2010-11-09 | |
| 2010-06-30 | $17.35M 10-Q · filed 2010-08-09 | |
| 2009-12-31 | $14.98M 10-K · filed 2011-03-01 |